Adrenergic blockade of hypocapnic cerebral arterial constriction.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001488:Basilar Artery / Q000187:drug effects* / Q000294:innervation; D002245:Carbon Dioxide / Q000097:blood; D002395:Catecholamines / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D005453:Fluorescence; D000882:Haplorhini; D006863:Hydrogen-Ion Concentration; D007278:Injections, Spinal; D008251:Macaca; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D014655:Vascular Resistance / Q000187:drug effects; D014711:Vertebral Artery / Q000187:drug effects* / Q000294:innervation
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D009638:Norepinephrine